23 Jul, 2026
Breast imaging is a branch of diagnostic radiology that involves taking pictures of the breasts for either screening or diagnostic purposes. Breast imaging technologies are used on women's breast tissues to look for breast cancer and other conditions that might affect the breast. Mammograms, MRIs, and ultrasounds are the breast imaging procedures that are used the most frequently. Breast imaging technology that uses low-dose X-rays to find cancer early on before symptoms show up is known as mammography.
According to Straits Research, the global breast imaging market size was valued at $5.8 billion in 2025 and is projected to grow from $6.3 billion in 2026 to $12.07 billion by 2034, registering a CAGR of 8.48% during the forecast period (2026–2034).
Rising spending on breast cancer research will support the market growth forecast. For instance, the National Institute of Cancer reports that US funding for breast cancer research increased from USD 519.9 million in 2016 to USD 574.9 million in 2018. In addition, the Canadian Cancer Society announced the SU2C Canada Metastatic Breast Cancer Dream Team in August 2019. It was created by Stand Up to Cancer Canada (SU2C Canada) and the Canadian Institutes of Health Research. (CIHR). This program has received USD 6 million to conduct nationwide clinical trials and public awareness campaigns for the prevention and treatment of metastatic breast cancer. Key players' adoption of strategies like new product launches, product approvals, mergers and acquisitions, and strategic collaborations will further aid market growth in the ensuing years.
It is anticipated that developing regions like Asia-Pacific will propel future market growth. Effective early breast cancer diagnosis is urgently needed in developing countries because most cases are only discovered later, which raises mortality. In 2018, it was estimated that 8.2 million new cases of cancer and 5.2 million cancer-related deaths occurred in Southern, Eastern, and South-Eastern Asia. Women in Australia aged 50 to 74 are required to receive free mammograms every two years as part of the government's widespread screening program known as Breast Screen Australia. Additionally, the government is working hard to develop the healthcare sector, and raising public awareness will help the market grow. For instance, women in Australia between 50 and 74 must receive free mammograms every two years as part of the government's national screening program, BreastScreen Aotearoa. BreastScreen Aotearoa provides breast screenings for women in New Zealand between the ages of 45 and 69. Women who qualify can get a free mammogram every two years to look for breast cancer in its early stages.
North America is the most significant contributor to the global breast imaging market and is expected to grow at a CAGR of 7.88% during the forecast period. This is because of several factors, such as the high prevalence of the disease among women, rising public awareness of it, technological advancements in imaging equipment, and the presence of breast imaging equipment manufacturers in the region. Breast cancer is the most prevalent cancer in American women, and the average lifetime risk of the disease is 13% for all females. According to the American Cancer Society, the number of female breast cancer deaths in the country will be around 43,600 in 2021. Additionally, there will be around 281,550 new cases of invasive breast cancer in women and 49,290 new cases of ductal carcinoma in situ (DCIS). In addition, according to the Canadian Cancer Society, breast cancer was the second-leading cause of cancer-related deaths in women in Canada in 2019.
Europe is expected to grow at a CAGR of 9.19% during the forecast period. Europe has become a significant market for breast imaging due to its growing geriatric population, rising breast cancer prevalence, and well-developed healthcare system. The market for breast imaging will expand in the coming years due to the area's significant growth potential. Germany, Italy, and Portugal are the majority of European countries and territories with the highest median ages, between 14 and 20. Due to the high proportion of elderly people in the area, an increasing number of cancer patients are being diagnosed. With 95% of new breast cancer cases occurring in women 40 and older, the disease becomes more prevalent as people age. Europe has some of the world's most advanced and effective healthcare systems. The established healthcare system in the area is helping to fuel market growth for breast imaging.
sales@straitsresearch.com